Barclays analyst Etzer Darout raised the firm’s price target on Exelixis (EXEL) to $41 from $40 and keeps an Equal Weight rating on the shares following the earnings report.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXEL:
- Exelixis’s Strong Financial Performance and Growth Prospects Earns Buy Rating from Yaron Werber
- Exelixis Reports Strong Q3 2025 Financial Results
- Exelixis: Strong Growth Prospects and Strategic Focus Justify Buy Rating
- Exelixis Announces $750 Million Stock Repurchase Program
- Exelixis reports Q3 adjusted EPS 81c, consensus 67c